Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Falanga

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Leukemia|January 1, 1994
Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acidA Falanga, R Consonni, M Marchetti, et al.
Thrombosis Research|February 15, 1993
Supranormal antithrombin III levels induced by concentrate administration are ineffective in quenching thrombin generation in acute promyelocytic leukemiaF Rodeghiero, G Castaman, L Gugliotta, et al.
Blood|April 9, 1999
Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factorA Falanga, M Marchetti, V Evangelista, et al.
Blood|June 25, 1998
Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cellsA Falanga, R Consonni, M Marchetti, et al.
Thrombosis and Haemostasis|February 12, 1998
The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trialA Falanga, M N Levine, R Consonni, et al.
Microbial Pathogenesis|September 19, 2018
Polymicrobial antibiofilm activity of the membranotropic peptide gH625 and its analogueE de Alteriis, L Lombardi, A Falanga, et al.
Leukemia|June 16, 2006
Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factorG Cella, M Marchetti, A Vignoli, et al.
The American Journal of Physiology|November 1, 1983
Unbalanced plasma control of TxA2 and PGI2 synthesis in vitamin E-deficient ratsA Falanga, M G Doni, F Delaini, et al.
Cancer Research|December 1, 1986
Cancer procoagulant in human tumor cells: evidence from melanoma patientsM B Donati, C Gambacorti-Passerini, B Casali, et al.
Blood|August 1, 1995
Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acidA Falanga, L Iacoviello, V Evangelista, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Leukemia|January 1, 1994
Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acidA Falanga, R Consonni, M Marchetti, et al.
Thrombosis Research|February 15, 1993
Supranormal antithrombin III levels induced by concentrate administration are ineffective in quenching thrombin generation in acute promyelocytic leukemiaF Rodeghiero, G Castaman, L Gugliotta, et al.
Blood|April 9, 1999
Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factorA Falanga, M Marchetti, V Evangelista, et al.
Blood|June 25, 1998
Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cellsA Falanga, R Consonni, M Marchetti, et al.
Thrombosis and Haemostasis|February 12, 1998
The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trialA Falanga, M N Levine, R Consonni, et al.
Microbial Pathogenesis|September 19, 2018
Polymicrobial antibiofilm activity of the membranotropic peptide gH625 and its analogueE de Alteriis, L Lombardi, A Falanga, et al.
Leukemia|June 16, 2006
Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factorG Cella, M Marchetti, A Vignoli, et al.
The American Journal of Physiology|November 1, 1983
Unbalanced plasma control of TxA2 and PGI2 synthesis in vitamin E-deficient ratsA Falanga, M G Doni, F Delaini, et al.
Cancer Research|December 1, 1986
Cancer procoagulant in human tumor cells: evidence from melanoma patientsM B Donati, C Gambacorti-Passerini, B Casali, et al.
Blood|August 1, 1995
Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acidA Falanga, L Iacoviello, V Evangelista, et al.
Pageof 9